Activating beta-1-adrenoceptor antibodies are not associated with cardiomyopathies secondary to valvular or hypertensive heart disease

Journal of the American College of Cardiology

Volumn 34, Issue 5, 1999, Pages 1545-1551

  Jahns, Roland ^a,c   Boivin, Valérie ^b   Siegmund, Christian ^b   Boege, Fritz ^a   Lohse, Martin J ^a   Inselmann, Gerhard ^b  

^a Department of Internal Medicine Medizinische Poliklinik ^*  (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR; DIGITALIS; IMMUNOGLOBULIN G; NITRATE; RECEPTOR ANTIBODY;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; CARBOXY TERMINAL SEQUENCE; CARDIOMYOPATHY; CROSS REACTION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; HYPERTENSION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RABBIT; VALVULAR HEART DISEASE;

EID: 0033230055     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00381-2     Document Type: Article

References (20)

1. Borda E, Pascual J, Cossio P, et al. A circulating IgG in Chagas disease which binds to β-adrenoceptor of myocardium and modulates its activity. Clin Exp Immunol 1984;57:679-85.
2. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson Å, Hoebeke J. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the β 1-adrenoceptor with positive chronotropic effect. Circulation 1994;89:2760-7.
3. Fu LX, Hoebeke J, Matsui S, et al. Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension. Clin Immunol Immunopathol 1994;72:15-20.
4. Jahns R, Boivin V, Siegmund C, et al. Autoantibodies activating human β 1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999;99:649-54.
5. Jahns R, Siegmund C, Jahns V, et al. Probing human β1- and β2-adrenoceptors with domain-specific fusion protein antibodies. Eur J Pharmacol 1996;316:111-21.
6. Frielle T, Collins S, Daniel KW, et al. Cloning of the cDNA for the human β1-adrenergic receptor. Proc Natl Acad Sci USA 1987;84:7920-4.
7. Kobilka BK, Dixon RA, Frielle T, et al. cDNA for the human β2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 1987;84:46-50.
8. Lauritzen E, Masson M, Rubin I, Holm A. Dot immunobmding and immunoblotting of picogram and nanogram quantities of small peptides on activated nitrocellulose. J Immunol Methods 1990;131:257-67.
9. Reiländer H, Boege F, Vasudevan S, et al. Purification and functional characterization of the human β2-adrenergic receptor produced in baculovirus-infected insect cells. FEBS Lett 1991;282:441-4.
10. Mandrell RE, Zollinger WD. Use of a zwitterionic detergent for the restoration of the antibody-binding capacity of electroblotted meningococcal outer membrane proteins. J Immunol Methods 1984;67:1-11.
11. Limas CJ, Goldenberg IF, Limas C. Assessment of immune modulation of β-adrenergic pathways in human dilated cardiomyopathy: influence of methodologic factors. Am Heart J 1992;123:967-70.
12. Gether U, Lin S, Ghanouni P, et al. Agonists induce conformational changes in transmembrane domains III and VI of the β2-adrenoceptor. Eur Mol Biol Organ J 1997;16:6737-47.
13. Dohlman HG, Caron MG, De Blasi A, Frielle T, Lefkowitz RJ. Role of extracellular disulfide-bonded cysteines in the ligand binding function of the β 2-adrenergic receptor. Biochemistry 1990;29:2335-42.
14. Fraser CM. Site-directed mutagenesis of β-adrenergic receptors. Identification of conserved cysteme residues that independently affect ligand binding and receptor activation. J Biol Chem 1989;264:9266-70.
15. Magnusson Y, Hoyer S, Lengagne R, et al. Antigenic analysis of the second extra-cellular loop of the human β-adrenergic receptors. Clin Exp Immunol 1989;78:42-8.
16. Bristow MR, Gingurg R, Minobe W, et al. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med 1982;307:205-11.
17. Fraser CM, Venter JC. Anti-receptor antibodies in human disease. J Allergy Clin Immunol 1984;74:661-73.
18. Fu LX, Herlitz H, Wallukat G, et al. Functional autoimmune epitope on β1-adrenergic receptors in patients with malignant hypertension. Lancet 1994;344:1660-3.
19. Luther HP, Homuth V, Wallukat G. β 1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension 1997;29:678-82.
20. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against β-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989;64:97-103.